MedicaidPrior AuthMedium impact
mab2024110805
Pennsylvania Medicaid (DHS)·PA · Psychiatry, Pediatrics, Neurology +1 more·Provider Bulletin
Effective date
Jan 6, 2025
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid updated prior authorization requirements for antipsychotic medications, adding new criteria for non-preferred drugs with therapeutically equivalent preferred alternatives and requiring prior auth for prescriptions exceeding quantity limits. The changes include enhanced monitoring requirements for pediatric patients and specific renewal guidelines.
Action Required
Before January 6, 2025: Billing team must update prior authorization tracking systems to flag antipsychotic prescriptions that are non-preferred when preferred therapeutically equivalent options exist, and prescriptions exceeding quantity limits. Providers treating pediatric patients under 18 with antipsychotics must ensure documentation includes comprehensive evaluation, non-pharmacologic therapy plans, baseline monitoring (BMI, blood pressure, glucose/A1c, lipid panel, AIMS), and for renewals, quarterly weight/BMI monitoring and annual lab monitoring. Front desk staff should verify specialist consultation requirements for pediatric cases (neurologist, child psychiatrist, or developmental pediatrician). Claims without proper prior authorization will be denied.